Globe Life Valuation

Is GL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GL ($110.07) is trading below our estimate of fair value ($365.15)

Significantly Below Fair Value: GL is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for GL?

Other financial metrics that can be useful for relative valuation.

GL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.1x
Enterprise Value/EBITDA8.2x
PEG Ratio2.2x

Price to Earnings Ratio vs Peers

How does GL's PE Ratio compare to its peers?

The above table shows the PE ratio for GL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average14.9x
PRI Primerica
14.5x6.8%US$10.1b
UNM Unum Group
7.4x-4.3%US$13.0b
CNO CNO Financial Group
14.8x10.9%US$4.1b
LNC Lincoln National
22.8x19.2%US$6.2b
GL Globe Life
8.5x3.8%US$9.3b

Price-To-Earnings vs Peers: GL is good value based on its Price-To-Earnings Ratio (8.5x) compared to the peer average (14.9x).


Price to Earnings Ratio vs Industry

How does GL's PE Ratio compare vs other companies in the US Insurance Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.4%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.4%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: GL is good value based on its Price-To-Earnings Ratio (8.5x) compared to the US Insurance industry average (13.2x).


Price to Earnings Ratio vs Fair Ratio

What is GL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio8.5x
Fair PE Ratio7.7x

Price-To-Earnings vs Fair Ratio: GL is expensive based on its Price-To-Earnings Ratio (8.5x) compared to the estimated Fair Price-To-Earnings Ratio (7.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GL forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$110.07
US$130.20
+18.3%
17.7%US$188.00US$105.00n/a10
Nov ’25US$104.02
US$129.90
+24.9%
18.0%US$188.00US$104.00n/a10
Oct ’25US$103.71
US$110.11
+6.2%
21.1%US$160.00US$83.00n/a9
Sep ’25US$105.05
US$109.56
+4.3%
21.5%US$160.00US$83.00n/a9
Aug ’25US$92.95
US$107.67
+15.8%
24.3%US$160.00US$66.00n/a9
Jul ’25US$82.83
US$103.89
+25.4%
27.1%US$160.00US$62.00n/a9
Jun ’25US$82.76
US$106.44
+28.6%
28.2%US$160.00US$62.00n/a9
May ’25US$79.48
US$106.44
+33.9%
28.2%US$160.00US$62.00n/a9
Apr ’25US$114.13
US$137.67
+20.6%
7.5%US$160.00US$125.00n/a9
Mar ’25US$126.17
US$139.11
+10.3%
6.7%US$160.00US$125.00n/a9
Feb ’25US$120.05
US$135.56
+12.9%
8.3%US$160.00US$115.00n/a9
Jan ’25US$121.72
US$133.56
+9.7%
8.9%US$160.00US$115.00n/a9
Dec ’24US$123.34
US$131.56
+6.7%
9.0%US$160.00US$115.00n/a9
Nov ’24US$116.37
US$130.78
+12.4%
9.4%US$160.00US$115.00US$104.029
Oct ’24US$108.73
US$126.44
+16.3%
5.4%US$138.00US$115.00US$103.719
Sep ’24US$111.45
US$126.11
+13.2%
5.8%US$138.00US$115.00US$105.059
Aug ’24US$112.57
US$126.11
+12.0%
5.8%US$138.00US$115.00US$92.959
Jul ’24US$109.62
US$125.11
+14.1%
5.6%US$138.00US$115.00US$82.839
Jun ’24US$103.78
US$124.89
+20.3%
5.6%US$138.00US$115.00US$82.769
May ’24US$109.01
US$127.70
+17.1%
5.9%US$140.00US$115.00US$79.4810
Apr ’24US$110.02
US$129.00
+17.3%
5.9%US$140.00US$115.00US$114.139
Mar ’24US$121.66
US$130.44
+7.2%
5.0%US$141.00US$124.00US$126.179
Feb ’24US$120.20
US$128.00
+6.5%
6.2%US$140.00US$112.00US$120.059
Jan ’24US$120.55
US$121.89
+1.1%
8.7%US$140.00US$112.00US$121.729
Dec ’23US$120.41
US$120.44
+0.03%
7.3%US$138.00US$112.00US$123.349
Nov ’23US$114.20
US$119.00
+4.2%
7.9%US$138.00US$112.00US$116.379

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies